Get the Stockscreener App
1.605
3.76%
-0.055
Alector Inc stock is traded at $1.605, with a volume of 457.24K.
It is down -3.76% in the last 24 hours and down -6.02% over the past month.
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.
See More
Previous Close:
$1.66
Open:
$1.66
24h Volume:
457.24K
Relative Volume:
0.39
Market Cap:
$164.48M
Revenue:
$97.06M
Net Income/Loss:
$-130.39M
P/E Ratio:
-1.0355
EPS:
-1.55
Net Cash Flow:
$-186.54M
1W Performance:
-14.57%
1M Performance:
-6.02%
6M Performance:
-69.34%
1Y Performance:
-77.14%
1-Day Range:
$1.5509
$1.685
1-Week Range:
$1.5509
$2.09
52-Week Range:
$1.55
$7.57
Alector Inc Stock (ALEC) Company Profile
Name
Alector Inc
Sector
Industry
Phone
415-231-5660
Address
131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO
Compare ALEC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ALEC
Alector Inc
|
1.605 | 164.48M | 97.06M | -130.39M | -186.54M | -1.55 |
|
VRTX
Vertex Pharmaceuticals Inc
|
475.77 | 121.85B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
696.41 | 76.83B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
616.37 | 37.96B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
241.91 | 30.69B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beone Medicines Ltd Adr
|
267.79 | 29.71B | 3.32B | -860.46M | -1.04B | -8.32 |
Alector Inc Stock (ALEC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-17-24 | Downgrade | Mizuho | Outperform → Neutral |
| Dec-16-24 | Downgrade | Stifel | Buy → Hold |
| Dec-04-24 | Downgrade | BofA Securities | Neutral → Underperform |
| Nov-29-24 | Reiterated | H.C. Wainwright | Buy |
| Nov-26-24 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Dec-14-23 | Upgrade | Stifel | Hold → Buy |
| Dec-12-23 | Initiated | Deutsche Bank | Buy |
| Sep-25-23 | Initiated | Goldman | Sell |
| Sep-22-23 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-06-23 | Downgrade | BofA Securities | Buy → Neutral |
| Sep-09-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jul-07-22 | Initiated | Mizuho | Buy |
| Apr-13-22 | Initiated | Goldman | Sell |
| Mar-08-22 | Downgrade | Stifel | Buy → Hold |
| Sep-27-21 | Initiated | William Blair | Outperform |
| Jan-15-21 | Resumed | BofA Securities | Buy |
| Jun-24-20 | Initiated | H.C. Wainwright | Buy |
| Apr-28-20 | Initiated | Goldman | Buy |
| Mar-06-20 | Initiated | Citigroup | Buy |
| Feb-27-20 | Initiated | Barclays | Overweight |
| Feb-19-20 | Initiated | Stifel | Buy |
| Nov-21-19 | Initiated | BTIG Research | Buy |
| Mar-04-19 | Initiated | Barclays | Overweight |
| Mar-04-19 | Initiated | BofA/Merrill | Buy |
| Mar-04-19 | Initiated | Morgan Stanley | Overweight |
| Mar-04-19 | Initiated | SVB Leerink | Outperform |
View All
Alector Inc Stock (ALEC) Latest News
Alector (NASDAQ:ALEC) Receives "Buy" Rating from HC Wainwright - MarketBeat
Alector’s Earnings Call: Progress Amid Challenges - TipRanks
Alector Inc (ALEC) Shares Up Despite Recent Market Volatility - The News Heater
Alector, Inc. (NASDAQ:ALEC) Q4 2024 Earnings Call Transcript - Insider Monkey
Earnings call transcript: Alector Inc Q4 2024 sees cautious market reaction By Investing.com - Investing.com South Africa
Alector Inc (ALEC) Q4 2024 Earnings Call Highlights: Strong Cash Position and Promising Clinical Advances - GuruFocus.com
Alector: Q4 Earnings Snapshot - mySA
The Bold Bet on Brain Health: Alector’s Race Against Time in Neurodegenerative Research - Smartphone Magazine
Alector Inc (NASDAQ:ALEC): The Biotech Pioneering New Frontiers in Neurodegenerative Diseases - Jomfruland.net
Alector Inc (ALEC) Q4 2024 Earnings Call Highlights: Strong Cash Position and Promising ... - Yahoo Finance
Alector, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024 - Marketscreener.com
Alector’s 2024 Financial Results and Clinical Advancements - TipRanks
Alector (ALEC) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance
Earnings call transcript: Alector Inc Q4 2024 sees cautious market reaction - Investing.com
Alector beats Q4 estimates, shares edge higher By Investing.com - Investing.com Canada
Alector beats Q4 estimates, shares edge higher - Investing.com India
Alector, Inc. SEC 10-K Report - TradingView
Alector Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - GlobeNewswire
Can Alector's $413M Cash Position Fuel Its Alzheimer's Breakthrough? Q4 Results Reveal Strategy - StockTitan
Alector Inc (ALEC) Q4 2024 Earnings Report Preview: What to Expect - Yahoo Finance
Alector to Participate in Upcoming Healthcare Conferences - GlobeNewswire
Can Alector's March Conference Circuit Signal Progress in Neurodegeneration Therapies? - StockTitan
Alector Inc expected to post a loss of 64 cents a shareEarnings Preview - TradingView
Alector (ALEC) Projected to Post Quarterly Earnings on Wednesday - Defense World
Alector, Inc. (NASDAQ:ALEC) Stock Position Lifted by Vontobel Holding Ltd. - Defense World
Alector to Host Fourth Quarter and Full-Year 2024 Earnings Conference Call - GlobeNewswire
When Will Alector Report Q4 Earnings? Key Date for Biotech Investors - StockTitan
February 2025 US Penny Stocks With Promising Prospects - Simply Wall St
Alector (ALEC) to Release Quarterly Earnings on Tuesday - MarketBeat
25,000 Shares in Alector, Inc. (NASDAQ:ALEC) Acquired by Apollon Wealth Management LLC - Defense World
SG Americas Securities LLC Acquires 8,581 Shares of Alector, Inc. (NASDAQ:ALEC) - Defense World
Alector, Inc. (NASDAQ:ALEC) Receives $3.75 Consensus PT from Analysts - MarketBeat
Alector stock hits 52-week low at $1.59 amid market challenges - Investing.com Nigeria
Alector, Inc. (NASDAQ:ALEC) Receives $3.75 Average Target Price from Brokerages - Defense World
Alector Reports Third Quarter 2023 Financial Results and Provides Business Update - br.ADVFN.com
Alector stock hits 52-week low at $1.59 amid market challenges By Investing.com - Investing.com South Africa
Alector Reports Third Quarter 2024 Financial Results and Provides Business Update - br.ADVFN.com
Alector Inc (NASDAQ: ALEC) Has Succeeded To Excite In 2025, The Stock Is Down -7.41% Year-To-Date - Marketing Sentinel
ALEC Stock Sees Surge of Approximately 12.20% in Last Five Days - Knox Daily
Alector, Inc. (NASDAQ:ALEC) Short Interest Down 8.5% in January - MarketBeat
AbbVie terminates Alector collaboration agreement - MSN
Cantor Fitzgerald Comments on Alector FY2025 Earnings - Defense World
Alector Inc Stock (ALEC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Alector Inc Stock (ALEC) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Rosenthal Arnon | Chief Executive Officer |
Dec 02 '24 |
Sale |
2.52 |
52,172 |
131,442 |
2,507,074 |
| Kenkare-Mitra Sara | President and Head of R&D |
Dec 02 '24 |
Sale |
2.52 |
26,500 |
66,764 |
565,215 |
| Romano Gary | Chief Medical Officer |
Dec 02 '24 |
Sale |
2.52 |
14,892 |
37,519 |
349,283 |
1.31%
0.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):